A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 48,200 shares of WST stock, worth $15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,200
Previous 47,000 2.55%
Holding current value
$15 Million
Previous $15.5 Million 6.55%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$277.16 - $333.3 $64.4 Million - $77.4 Million
-232,218 Reduced 82.83%
48,126 $14.4 Million
Q2 2024

Aug 14, 2024

SELL
$314.68 - $395.94 $245 Million - $309 Million
-779,802 Reduced 73.56%
280,344 $92.3 Million
Q1 2024

May 15, 2024

BUY
$338.27 - $413.0 $44.4 Million - $54.2 Million
131,129 Added 14.11%
1,060,146 $420 Million
Q4 2023

Feb 14, 2024

SELL
$318.29 - $392.21 $198 Million - $244 Million
-622,761 Reduced 40.13%
929,017 $327 Million
Q3 2023

Nov 14, 2023

BUY
$354.9 - $412.41 $177 Million - $206 Million
498,447 Added 47.32%
1,551,778 $582 Million
Q2 2023

Aug 14, 2023

SELL
$334.63 - $382.47 $15.3 Million - $17.5 Million
-45,851 Reduced 4.17%
1,053,331 $403 Million
Q1 2023

May 15, 2023

BUY
$232.5 - $346.47 $218 Million - $325 Million
938,098 Added 582.37%
1,099,182 $381 Million
Q4 2022

Feb 14, 2023

SELL
$209.34 - $261.61 $11.7 Million - $14.6 Million
-55,815 Reduced 25.73%
161,084 $37.9 Million
Q3 2022

Nov 14, 2022

BUY
$246.08 - $343.65 $20.2 Million - $28.2 Million
81,966 Added 60.75%
216,899 $53.4 Million
Q2 2022

Aug 15, 2022

SELL
$280.61 - $420.45 $73 Million - $109 Million
-260,198 Reduced 65.85%
134,933 $40.8 Million
Q1 2022

May 16, 2022

BUY
$357.49 - $445.92 $141 Million - $176 Million
394,115 Added 38790.85%
395,131 $162 Million
Q4 2021

Feb 14, 2022

SELL
$402.25 - $471.34 $22.1 Million - $25.9 Million
-54,943 Reduced 98.18%
1,016 $476,000
Q3 2021

Nov 15, 2021

BUY
$363.01 - $468.47 $10.3 Million - $13.2 Million
28,271 Added 102.11%
55,959 $23.8 Million
Q2 2021

Aug 16, 2021

BUY
$284.77 - $363.2 $3.13 Million - $3.99 Million
10,977 Added 65.69%
27,688 $9.94 Million
Q4 2020

Feb 16, 2021

BUY
$261.16 - $301.66 $3.01 Million - $3.48 Million
11,541 Added 223.23%
16,711 $4.73 Million
Q3 2020

Nov 16, 2020

SELL
$224.99 - $288.02 $30.6 Million - $39.1 Million
-135,855 Reduced 96.33%
5,170 $1.42 Million
Q2 2020

Aug 14, 2020

BUY
$149.8 - $227.17 $19.3 Million - $29.3 Million
128,809 Added 1054.43%
141,025 $32 Million
Q1 2020

May 15, 2020

SELL
$128.96 - $174.76 $2.97 Million - $4.03 Million
-23,052 Reduced 65.36%
12,216 $1.86 Million
Q4 2019

Feb 14, 2020

SELL
$137.6 - $151.21 $12.8 Million - $14.1 Million
-93,193 Reduced 72.55%
35,268 $5.3 Million
Q3 2019

Nov 14, 2019

BUY
$121.41 - $150.02 $8.09 Million - $10 Million
66,639 Added 107.79%
128,461 $18.2 Million
Q2 2019

Aug 14, 2019

BUY
$111.27 - $125.15 $5.45 Million - $6.14 Million
49,024 Added 383.06%
61,822 $7.74 Million
Q1 2019

May 15, 2019

BUY
$94.53 - $110.2 $897,373 - $1.05 Million
9,493 Added 287.23%
12,798 $0
Q4 2018

Feb 14, 2019

BUY
$93.0 - $123.98 $45,291 - $60,378
487 Added 17.28%
3,305 $323,000
Q3 2018

Nov 13, 2018

SELL
$98.01 - $123.47 $55,669 - $70,130
-568 Reduced 16.77%
2,818 $0
Q2 2018

Aug 10, 2018

SELL
$83.32 - $101.88 $2.82 Million - $3.44 Million
-33,803 Reduced 90.9%
3,386 $0
Q1 2018

May 11, 2018

BUY
$85.56 - $102.4 $384,335 - $459,980
4,492 Added 13.74%
37,189 $3.28 Million
Q4 2017

Feb 09, 2018

BUY
$91.65 - $101.65 $2.57 Million - $2.85 Million
28,054 Added 604.22%
32,697 $3.23 Million
Q3 2017

Nov 09, 2017

BUY
$84.54 - $96.75 $392,519 - $449,210
4,643
4,643 $447,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $23.1B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.